Compandia Appoints Dr Dave Tapolcazy as new Non Executive Chairman
News May 14, 2010
Compandia announces the appointment of its new non exec chairman Dr Dave Tapolczay. Dave is CEO of Medical Research Council Technology, the commercialization company for the MRC.
Compandia CEO, Andy Sutton announced, “We are thrilled that Dave has joined Compandia and will bring significant experience from his years at GSK, Millenium, Pharmorphix and AZ. Dave will add a strategic view from both the large International Corporate and Start Up perspectives and bring a wealth of knowledge regarding current trends affecting the Pharma and Biotech Sectors which will assist Compandia in positioning its services for optimal delivery”.
Compandia is a biomarker discovery and bioinformatics spin out from Nottingham Trent University. Compandia uses advanced bioinformatics tools to derive biomarker panels from complex biological data being generated in the Pharmaceutical, Biotech and Biomedical sectors.
Compandia claims that it’s advantage is the ability to find small biomarker panels from data that would otherwise be impossible to decipher this enables disease states to be accurately diagnosed from a small number of analytes.
Compandia in addition offers proteomic services coupled to its “Biomarker Distiller” for the discovery of proteomic biomarker panels.
Compandia also announced the launch of a new bioinformatics capability, its “Pathways Distiller” bioinformatics tool that creates maps of interacting gene pathways which define patient populations such as drug responders from non responders.
Have you ever been stressed out by the idea of doing math or statistics problems? You’re not alone. A new study has used a questionnaire and an analytical technique called "network science" to determine precisely what factors contribute to this kind of statistics anxiety among psychology majors.
Anxiety and depression are surprisingly common among young children. But it can be hard to detect these conditions, known as “internalizing disorders,” because the symptoms are so inward-facing that parents, teachers and doctors often fail to notice them. Now, researchers have developed a tool that could help screen children for internalizing disorders to catch them early enough to be treated.
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019